203 related articles for article (PubMed ID: 35881977)
1. Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis).
Sayed Ahmed A; Abreo M; Thomas A; Chari ST
Curr Opin Gastroenterol; 2022 Sep; 38(5):516-520. PubMed ID: 35881977
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury.
Abu-Sbeih H; Tang T; Lu Y; Thirumurthi S; Altan M; Jazaeri AA; Dadu R; Coronel E; Wang Y
J Immunother Cancer; 2019 Feb; 7(1):31. PubMed ID: 30728076
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor-Induced (Type 3) Autoimmune Pancreatitis.
Shirwaikar Thomas A; Chari ST
Curr Gastroenterol Rep; 2023 Oct; 25(10):255-259. PubMed ID: 37845557
[TBL] [Abstract][Full Text] [Related]
4. Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor Therapy.
Townsend MJ; Liu M; Giobbie-Hurder A; Sack JS; LeBoeuf NR; Hodi FS; McNabb-Baltar J; Grover S
J Natl Compr Canc Netw; 2023 Aug; 21(8):831-840.e3. PubMed ID: 37549912
[TBL] [Abstract][Full Text] [Related]
5. Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Grimmelmann I; Momma M; Zimmer L; Hassel JC; Heinzerling L; Pföhler C; Loquai C; Ruini C; Utikal J; Thoms KM; Kähler KC; Eigentler T; Herbst RA; Meier F; Debus D; Berking C; Kochanek C; Ugurel S; Gutzmer R;
Eur J Cancer; 2021 May; 149():1-10. PubMed ID: 33812141
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitor-induced Pancreatitis with Pancreatic Enlargement Mimicking Autoimmune Pancreatitis: A Case Report and Review of the Literature.
Tanabe K; Yokoyama K; Kanno A; Ikeda E; Ando K; Nagai H; Koyanagi T; Sakaguchi M; Nakaya T; Tamada K; Niki T; Fukushima N; Lefor AK; Yamamoto H
Intern Med; 2024 Mar; 63(6):791-798. PubMed ID: 37532549
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic adverse events of immune checkpoint inhibitors therapy for solid cancer patients: a systematic review and meta-analysis.
Zhao Z; Zhang W; Pang L; Zeng L; Liu S; Liu J
Front Immunol; 2023; 14():1166299. PubMed ID: 37359551
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary Adverse Events.
Abu-Sbeih H; Wang Y
Adv Exp Med Biol; 2020; 1244():271-276. PubMed ID: 32301021
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Pancreatic Injury and Pancreatitis in Patients Treated With Immune Checkpoint Inhibitors.
Hori Y; Naitoh I; Naiki-Ito A; Kawai T; Yoshida M; Kato A; Kachi K; Sahashi H; Adachi A; Toyohara T; Kito Y; Yamamoto T; Takahashi S; Kataoka H
Clin Transl Gastroenterol; 2024 Apr; 15(4):e00667. PubMed ID: 38088372
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.
Nagao K; Sakai A; Tsumura H; Iemoto T; Hirata Y; Hori H; Ogisu K; Kakuyama S; Ikegawa T; Hirata T; Ezaki T; Furumatsu K; Yamanaka K; Kato T; Fujigaki S; Tanaka H; Yagi Y; Tanaka T; Kobayashi T; Masuda A; Shiomi H; Kodama Y
J Gastroenterol; 2024 May; 59(5):424-433. PubMed ID: 38421473
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes and Pancreatitis.
Zhang AL; Wang F; Chang LS; McDonnell ME; Min L
Front Endocrinol (Lausanne); 2021; 12():620522. PubMed ID: 33927691
[TBL] [Abstract][Full Text] [Related]
12. Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis.
George J; Bajaj D; Sankaramangalam K; Yoo JW; Joshi NS; Gettinger S; Price C; Farrell JJ
Pancreatology; 2019 Jun; 19(4):587-594. PubMed ID: 31076344
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Pancreatitis Secondary to Immune Checkpoint Inhibitor Therapy (Type 3 AIP): Insights Into a New Disease From Serial Pancreatic Imaging.
Thomas AS; Abreo M; Sayed SA; Sireesha Yedururi YW; Chari ST
Gastroenterology; 2023 Jan; 164(1):154-155. PubMed ID: 36220459
[No Abstract] [Full Text] [Related]
14. Hepatobiliary and Pancreatic Adverse Events.
Zhang HC; Wang LS; Miller E
Adv Exp Med Biol; 2021; 1342():339-355. PubMed ID: 34972973
[TBL] [Abstract][Full Text] [Related]
15. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
[TBL] [Abstract][Full Text] [Related]
16. Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion.
Kramer S; van Hee K; Blokzijl H; van der Heide F; Visschedijk MC
J Immunother; 2023 Sep; 46(7):271-275. PubMed ID: 37216403
[TBL] [Abstract][Full Text] [Related]
17. Management of autoimmune and viral hepatitis in immunotherapy: a narrative review.
Kuo L; Kuwelker S; Tsai E
Ann Palliat Med; 2023 Nov; 12(6):1275-1294. PubMed ID: 37731304
[TBL] [Abstract][Full Text] [Related]
18. [Immune-Related Pancreatitis Caused by Immune Checkpoint Inhibitor Nivolumab:Report of One Case].
Xu F; Shen Z; Tao H; Zhu Z; Tao JL; Feng ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):351-354. PubMed ID: 37157088
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of autoimmune pancreatitis.
Sugumar A
Gastroenterol Clin North Am; 2012 Mar; 41(1):9-22. PubMed ID: 22341247
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune pancreatitis type 2.
de Pretis N; Frulloni L
Curr Opin Gastroenterol; 2020 Sep; 36(5):417-420. PubMed ID: 32618613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]